Nanobody-mediated control of gene expression and epigenetic memory.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33483487.
- Also identified by DOI 10.1038/s41467-020-20757-1 and PMC identifier 7822885.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Targeting chromatin regulators to specific genomic locations for gene control is emerging as a powerful method in basic research and synthetic biology. However, many chromatin regulators are large, making them difficult to deliver and combine in mammalian cells. Here, we develop a strategy for gene control using small nanobodies that bind and recruit endogenous chromatin regulators to a gene. We show that an antiGFP nanobody can be used to simultaneously visualize GFP-tagged chromatin regulators and control gene expression, and that nanobodies against HP1 and DNMT1 can silence a reporter gene. Moreover, combining nanobodies together or with other regulators, such as DNMT3A or KRAB, can enhance silencing speed and epigenetic memory. Finally, we use the slow silencing speed and high memory of antiDNMT1 to build a signal duration timer and recorder. These results set the basis for using nanobodies against chromatin regulators for controlling gene expression and epigenetic memory.
Medical subject headings
- Chromatin
- Epigenesis, Genetic
- Gene Expression Regulation
- Promoter Regions, Genetic
- Single-Domain Antibodies